Leuprorelin, also known as leuprolide. It is used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty. Reference standards of Leuprorelin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Leuprorelin
Catalogue No.:PA 12 92000
CAS :
Molecular Formula : C59H84N16O12
Molecular Weight : 1209.4
[4-D-serine]leuprorelin
Catalogue No.:PA 12 92010
Molecular Formula : NA
Molecular Weight : NA
[2-D-Histidine]leuprorelin
Catalogue No.:PA 12 92020
[6-L-Leucine]leuprorelin
Catalogue No.:PA 12 92030
[4-(O-Acetyl-L-serine)]leuprorelin
Catalogue No.:PA 12 92040
Molecular Formula : C61H86N16O13
Molecular Weight : 1251.46
[3-D-Tryptophane]leuprorelin
Catalogue No.:PA 12 92050
Molecular Weight : 1209.42
[2-D-Histidine,4-D-serine]leuprorelin
Catalogue No.:PA 12 92060
[5-D-Tyrosine]leuprorelin
Catalogue No.:PA 12 92070
[7-D-Leucine]leuprorelin
Catalogue No.:PA 12 92080
[1-(5-Oxo-D-proline)]leuprorelin
Catalogue No.:PA 12 92090
[8-[5-N-[Imino(1H-pyrazol-1-yl)methyl]-L-ornithine]]leuprorelin
Catalogue No.:PA 12 92100
[4-Dehydroalanine]leuprorelin
Catalogue No.:PA 12 92110
Leuprorelin Acetate (JP 0130)
Catalogue No.:PA JP0130
Leuprorelin (L0376000)
Catalogue No.:PA EPL0376000
Leuprorelin - reference spectrum (L0376001)
Catalogue No.:PA EPL0376001
[6-L-leucine]leuprorelin
Catalogue No.:PA 12 0920030
((R)-5-Oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophan
Catalogue No.:PA 12 0921000
Molecular Formula : C22H24N6O5
Molecular Weight : 452.47
L-Seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide
Catalogue No.:PA 12 0921001
Molecular Formula : C37H62N10O8
Molecular Weight : 774.97
Des-Pyr-Leuprolide
Catalogue No.:PA 12 0921002
Molecular Formula : C54H79N15O10
Molecular Weight : 1098.32
5-9-Leuprolide
Catalogue No.:PA 12 0921003
Molecular Formula : C34H57N9O6
Molecular Weight : 687.89
Des-Tyr(14)-Linaclotide
Catalogue No.:PA 12 0921004
Molecular Formula : C50H70N14O19S6
Molecular Weight : 1363.55
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
